Invivyd (IVVD) Accumulated Expenses (2020 - 2025)
Invivyd (IVVD) posted Accumulated Expenses of $19.1 million for Q4 2025, down 24.62% on a QoQ basis from $25.3 million in Q3 2025, and down 62.04% year-over-year from $50.2 million in Q4 2024.
Invivyd (IVVD) Accumulated Expenses (2020 - 2025) Analysis & Trends
Invivyd's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $19.1 million for Q4 2025.
- Quarterly Accumulated Expenses fell 62.04% year-over-year to $19.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $19.1 million (down 62.04% YoY) and the FY2025 annual result came in at $19.1 million, down 62.04% from the prior year.
- Accumulated Expenses was $19.1 million for Q4 2025 at Invivyd, down from $25.3 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $76.5 million in Q1 2022 and bottomed at $14.5 million in Q1 2023.
- A 5-year average of $35.6 million and a median of $29.0 million in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Accumulated Expenses jumped 1044.07% — and 2023, when it slumped 81.05%.
- Invivyd's Accumulated Expenses stood at $56.3 million in 2021, then plunged by 61.07% to $21.9 million in 2022, then jumped by 86.48% to $40.9 million in 2023, then gained by 22.85% to $50.2 million in 2024, then sank by 62.04% to $19.1 million in 2025.
- Business Quant data shows IVVD's Accumulated Expenses at $19.1 million in Q4 2025, $25.3 million in Q3 2025, and $25.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Invivyd | 104.07 Mn | -122.62 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.05 Mn |
| Sep 30, 2025 | 25.28 Mn |
| Jun 30, 2025 | 25.31 Mn |
| Mar 31, 2025 | 39.93 Mn |
| Dec 31, 2024 | 50.20 Mn |
| Sep 30, 2024 | 59.40 Mn |
| Jun 30, 2024 | 26.82 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 40.86 Mn |
| Sep 30, 2023 | 15.96 Mn |
| Jun 30, 2023 | 26.74 Mn |
| Mar 31, 2023 | 14.50 Mn |
| Dec 31, 2022 | 21.91 Mn |
| Sep 30, 2022 | 28.97 Mn |
| Jun 30, 2022 | 52.62 Mn |
| Mar 31, 2022 | 76.54 Mn |
| Dec 31, 2021 | 56.28 Mn |
| Sep 30, 2021 | 35.49 Mn |
| Jun 30, 2021 | 27.18 Mn |
| Dec 31, 2020 | 4.92 Mn |